Frank Takkinen
Stock Analyst at Lake Street
(0.62)
# 3,717
Out of 4,814 analysts
55
Total ratings
19.23%
Success rate
-24.42%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CVRX CVRx, Inc. | Maintains: Buy | $19 → $14 | $6.25 | +124.00% | 7 | Apr 8, 2025 | |
LNSR LENSAR | Downgrades: Hold | $16 → $15 | $13.90 | +7.91% | 2 | Mar 24, 2025 | |
HYPR Hyperfine | Initiates: Buy | $1.5 | $0.69 | +117.36% | 1 | Mar 24, 2025 | |
AXGN Axogen | Initiates: Buy | $30 | $15.56 | +92.80% | 1 | Mar 17, 2025 | |
SGHT Sight Sciences | Maintains: Hold | $3 → $2.5 | $2.69 | -7.06% | 3 | Mar 6, 2025 | |
CLBT Cellebrite DI | Maintains: Buy | $17 → $26 | $18.88 | +37.71% | 3 | Feb 14, 2025 | |
CLPT ClearPoint Neuro | Maintains: Buy | $17 → $30 | $12.25 | +144.90% | 4 | Jan 21, 2025 | |
KRMD KORU Medical Systems | Maintains: Buy | $4 → $5 | $2.26 | +121.73% | 2 | Jan 14, 2025 | |
AVR Anteris Technologies Global | Initiates: Buy | $20 | $2.88 | +595.65% | 1 | Jan 8, 2025 | |
NSPR InspireMD | Initiates: Buy | $5 | $2.59 | +93.05% | 1 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2 → $4 | $1.64 | +144.65% | 6 | Sep 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $0.94 | +750.16% | 2 | Aug 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $22.93 | +30.86% | 2 | Jul 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $2.32 | +331.03% | 2 | Jun 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $4.52 | +165.49% | 1 | Jun 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $1.34 | +347.76% | 2 | Apr 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.83 | +118.58% | 2 | Mar 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $10.80 | +11.11% | 2 | Dec 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $305 → $350 | $150.00 | +133.33% | 1 | Aug 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $5 | $3.23 | +54.80% | 3 | Jul 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $0.99 | +811.39% | 3 | Jun 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $1.38 | +1,059.42% | 2 | May 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.71 | +1,200.00% | 2 | Jan 18, 2023 |
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $6.25
Upside: +124.00%
LENSAR
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $13.90
Upside: +7.91%
Hyperfine
Mar 24, 2025
Initiates: Buy
Price Target: $1.5
Current: $0.69
Upside: +117.36%
Axogen
Mar 17, 2025
Initiates: Buy
Price Target: $30
Current: $15.56
Upside: +92.80%
Sight Sciences
Mar 6, 2025
Maintains: Hold
Price Target: $3 → $2.5
Current: $2.69
Upside: -7.06%
Cellebrite DI
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $18.88
Upside: +37.71%
ClearPoint Neuro
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $12.25
Upside: +144.90%
KORU Medical Systems
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $2.26
Upside: +121.73%
Anteris Technologies Global
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $2.88
Upside: +595.65%
InspireMD
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $2.59
Upside: +93.05%
Sep 30, 2024
Upgrades: Buy
Price Target: $2 → $4
Current: $1.64
Upside: +144.65%
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $0.94
Upside: +750.16%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $22.93
Upside: +30.86%
Jun 21, 2024
Maintains: Buy
Price Target: $5 → $10
Current: $2.32
Upside: +331.03%
Jun 4, 2024
Initiates: Buy
Price Target: $12
Current: $4.52
Upside: +165.49%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $1.34
Upside: +347.76%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $1.83
Upside: +118.58%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $10.80
Upside: +11.11%
Aug 2, 2023
Maintains: Buy
Price Target: $305 → $350
Current: $150.00
Upside: +133.33%
Jul 19, 2023
Maintains: Buy
Price Target: $2.5 → $5
Current: $3.23
Upside: +54.80%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $0.99
Upside: +811.39%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $1.38
Upside: +1,059.42%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.71
Upside: +1,200.00%